EPAS1 and renal cell carcinoma: Two compounds, PT2385 and PT2399, were shown to bind directly and selectively to HIF-2α and block its dimerization with HIF-1β, thereby inhibiting the expression of HIF-2 target genes and the growth of HIF-2–dependent RCC xenografts (162–164).